Moreover, HMOX1 exhibits increased activity in cancer cells, resulting in the accumulation of tumour malignancy and the enhancement of apoptotic ability in ovarian cancer [33] and bladder cancer [34]. This evidence concerns the gene HMOX1 and urinary bladder carcinoma.